References
- 1. Bukhari M. H., Niazi S., Khan S. A., Hashmi I., Perveen S., 2007: Modified method of AgNOR staining for tissue interpretation in histopathology. Int. J. Exp. Pathol., 88, 47—53.
- 2. Cronin, K., Loftus, B. M., Dervan, P. A., 1989: Are AgNORs useful in distinguishing follicular hyperplasia from follicular lymphoma ? J. Clin. Pathol., 42, 1267—1268.
- 3. Derenzini, M., Trere, D., 1994: AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralblatt fűr Pathologie, 14, 7—10.
- 4. Garcia-Moreno, L. M., Cimadevilla, J. M., Gonzalez-Pardo, H., Arias, J. L., 2000: Functional differences between ventral and dorsal hippocampus revealed with AgNOR staining. Psicothema, 12, 293—295.
- 5. Goodpasture, C., Blossom, S. E., 1975: Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromosoma, 53, 37.
- 6. Imamoglu, N., Demirtas, H., Donmez-Altuntas, H., Ilten, A., 2005: Higher NORs expression in lymphocyte of trisomy 21 babies/children: In vivo evaluation. Micron, 36, 503—507.
- 7. Imamoglu, N., Eroz, R., Canatan, H., Demirtas, H., Saatci, C., 2016: Nuclear AgNOR protein enhancement in nucleoplasms of peripheral blood lymphocytes of babies/children with Down syndrome. Microscopy Res. Tech., 79,133—139.
- 8. Jelisijevic, T., Jovanovic, M., Knezevic, M., Aleksic-Kovacecic, S., 2003: Quantitative and qualitative analysis of AgNOR in benign and malignant canine mammary gland tumours. Acta Veterinaria (Beograd), 53, 353—360.
- 9. Johnson, G. C., Miller, M. A., Ramos-Vara, J. A., 1995: Comparison of agyrophilic nucleolar organizer regions and mitotic index in distinguishing benign from malignant canine smooth muscle tumours in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa. J. Vet. Diagn. Investigation, 7, 127—136.
- 10. Lindner, L. E., 1993: Improvements in silver-staining technique for nucleolar organizer regions. J. Histochem. Cytochem., 41, 439—445.
- 11. Mamaev, N. N., Salogub, G. N., Nefedov, I. B., 1997: Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts. J. Clin. Pathol. Mol. Pathol., 50, 92—95.
- 12. Manu, V., Rajram, T., Rai R., 2006: Value of silver binding nucleolar organizer regions in squamous cell carcinomas of upper aero-digestive tract. MJAFI, 62, 123—128.
- 13. Mondal, N. K., Das, D., Mukherjee, B., Ray, M. R., 2011: Upregulation of AgNOR expression in epithelial cells and neutrophils in the airways and leukocytes in the peripheral blood of women chronically exposed to biomass smoke. Analyt. Quant. Cytol. Histol., 33, 50—59.
- 14. Ogunsola, J., Antia, R. E., 2018: Adaptation of a modified agyrophil technique to canine peripheral blood. Open Vet. J., 8, 182—185.
- 15. Parveen, S., Bukhari, M. H., Khan, S. A., Naveed, I. A., Chaudhry, N. A., 2006: AgNOR stain in normal cirrhotic and carcinomatous liver. Biomedica, 22, 59—61.
- 16. Ploton, D., Menager, M., Jeannesson, P., Himber, G., Pigeon, F., Adnet J. J., 1986: Improvement in the staining and visualization of the agyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem. J., 18, 5—14.
- 17. Pogorelov, V. M., Kozinets, G. I., Mikhailova, E. A., Medovy, V. S., Verdenskaya, N. V., Ivanova, I. A., et al., 1996: Discrimination and automated classification of apoptotic lymphocytes in silver-stained (AgNOR reaction) peripheral blood smears from patients with severe aplastic anaemia. Analyt. Quant. Cytol. Histol., 18, 92—93.
- 18. Rodrigues, O. R., Antonangelo, L., Yagi, N., Minamoto, H., Schmidt, A. F., et al., 1997: Prognostic significance of agyrophilic nucleolar organizer region in resected non-small cell lung cancer. Japanese J. Clin. Oncol., 27, 298—304.
- 19. Salehinejad, J., Kalantari, M. R., Omidi, A. A., Zare, R., 2007: Evaluation of AgNOR staining of exfoliative cytology of normal oral (buccal) mucosa: Effect of smoking. J. Mashdad Dental Sch., 31, 22—24.
- 20. Sur, E., Celik, I., Oznurlu, Y., Faruk-Aydin, M., Sen, I., Ozparlak, H., 2003: Enzyme histochemistry and AgNOR numbers in the peripheral blood leukocytes of 6 month-old Kangal-bred Anatolian shepherd dogs. Revue de Médecine Vétérinaire, 154, 591—598.
- 21. Trere, D., 2000: AgNOR quantitation and staining. Micron, 31, 127—131.
- 22. Vajdovich, P., Psader, R., Toth, Z. A., Perge, E., 2004: Use of the agyrophilic nucleolar region for cytologic and histologic examination of lymph nodes in dogs. Vet. Pathol., 41, 338—345.
- 23. Van Belle, S. J. P., Cocquyt, V., 2003: Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Critical Rev. Oncol./Hematol., 47, 1—11.
- 24. Wang, J. Y., Rong, T. H., Liang, Y. R., Long, H., Chen, Q. L., Ma, G. W., 2004: Diagnostic application of detecting AgNOR in peripheral blood T lymphocytes in patients with esophageal carcinoma. Ai Zheng, 23, 577—580.
- 25. Yasunaga, Y., Shin, M., Miki, T., Okuyama, A., and Aozasa, K., 1998: Prognostic factors of renal cell carcinoma: A multi-variate analysis. J. Surgical Oncol., 68, 11—18.